تخطي للذهاب إلى المحتوى

EDA Pharmacovigilance Inspection: What to Expect and How to Prepare

6 أغسطس 2026 بواسطة
EDA Pharmacovigilance Inspection: What to Expect and How to Prepare
EMCO Egypt

EDA Pharmacovigilance Inspection: What to Expect and How to Prepare

EDA inspections can arrive with two weeks' notice. The companies that pass are the ones whose system was already running before the notification came.

Our PV Services Contact Us

EDA pharmacovigilance inspections are increasing in frequency in Egypt. Companies managing more than 20 registered products, companies with recent variations or renewals, and companies that have received a serious adverse event report are among those most likely to receive notifications. The notification can arrive with as little as two weeks' notice. That is not enough time to build a pharmacovigilance system. It is enough time to prepare one that already exists.

What an EDA pharmacovigilance inspection covers

  • The pharmacovigilance system overall — documented, functioning, covering all registered products
  • The QPPV — qualification, availability, and actual oversight
  • Adverse event collection — training of all source channels, documented procedures, evidence of all events received
  • ICSR management — case documentation quality and 15-day expedited window compliance
  • Literature monitoring — systematic, documented searches at defined intervals
  • Signal detection — active surveillance, not just case processing
  • Aggregate reporting — PSURs prepared and submitted on schedule
  • Quality management — current SOPs, training records, internal audit evidence
Pharmaceutical regulatory inspection documentation review

The documentation package EDA expects on day one

  • Current PSMF — complete and updated
  • Complete product list covered by the PV system
  • ICSR database with intake and submission dates
  • Literature monitoring records — evidence of systematic searches
  • PSUR submission records — dates and reference numbers
  • PV SOP list with version numbers and review dates
  • Personnel training records for all staff with PV responsibilities
  • Internal audit reports

The most common findings

Critical
  • No functioning PV system for one or more products
  • Serious adverse events not reported or significantly late
  • QPPV not qualified or not in operational practice
Major
  • PSMF incomplete, outdated, or inconsistent
  • No evidence of literature monitoring
  • Adverse event training not documented
  • ICSRs submitted late
  • PSURs not prepared or submitted
Minor
  • SOP version control issues
  • PSMF not updated after portfolio changes
  • Training records incomplete
Inspection readiness preparation

How to prepare

Ongoing:

  • Keep your PSMF current — update it when products, personnel, or processes change
  • Conduct annual internal PV audits against your own PSMF
  • Maintain documented evidence of literature monitoring at scheduled intervals
  • Verify your ICSR database — every serious case must show a submission date within 15 days

When the notification arrives:

  • Assemble the day-one documentation package immediately
  • Brief the QPPV on the inspection scope
  • Review the ICSR database for any late submissions
  • Make documentation retrievable by product, by case, and by date

How EMCO Egypt supports inspection readiness

EMCO Egypt's pharmacovigilance outsourcing clients maintain inspection readiness as a continuous state. When an inspection notification arrives, the system is already in the state it needs to be. For regulatory affairs teams building their own competency, our QPPV training programme covers the inspection process in detail. Learn more about EMCO Egypt.

Common Questions About EDA Inspections

The next inspection will test your PV system. Is it ready?

A 30-minute conversation with EMCO Egypt will identify the gaps before the inspection notification arrives.

Request an Assessment View QPPV Training
What Is a PSMF and Why Does Your Pharma Company in Egypt Need One?